diethylcarbamazine has been researched along with Liver Cirrhosis in 3 studies
Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic inflammation was induced by i." | 5.40 | Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice. ( Barbosa, KP; de França, ME; Luna, RL; Nunes, AK; Oliveira, AG; Oliveira, WH; Pastor, AF; Peixoto, CA; Rocha, SW; Rodrigues, GB, 2014) |
| " The present study was designed to investigate the possible protective effects of diethylcarbamazine (DEC) (50mg/kg, acting as an anti-inflammatory drug, interferes with the arachidonic acid metabolism) when administrated in combination with hesperidin (HDN) (200mg/kg, a flavanone glycoside with potent antioxidant and anti-inflammatory activities) against alcoholic liver fibrosis in wistar rats compared to silymarin (Sil) (100mg/kg)." | 1.46 | Antifibrotic effect of diethylcarbamazine combined with hesperidin against ethanol induced liver fibrosis in rats. ( El-Sisi, AEE; Mohamed, DZ; Shebl, AM; Sokar, SS, 2017) |
| "Chronic inflammation was induced by i." | 1.40 | Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice. ( Barbosa, KP; de França, ME; Luna, RL; Nunes, AK; Oliveira, AG; Oliveira, WH; Pastor, AF; Peixoto, CA; Rocha, SW; Rodrigues, GB, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sisi, AEE | 1 |
| Sokar, SS | 1 |
| Shebl, AM | 1 |
| Mohamed, DZ | 1 |
| França, MER | 1 |
| Rocha, SWS | 1 |
| Oliveira, WH | 2 |
| Santos, LA | 1 |
| de Oliveira, AGV | 1 |
| Barbosa, KPS | 1 |
| Nunes, AKS | 1 |
| Rodrigues, GB | 2 |
| Lós, DB | 1 |
| Peixoto, CA | 2 |
| Rocha, SW | 1 |
| de França, ME | 1 |
| Barbosa, KP | 1 |
| Nunes, AK | 1 |
| Pastor, AF | 1 |
| Oliveira, AG | 1 |
| Luna, RL | 1 |
3 other studies available for diethylcarbamazine and Liver Cirrhosis
| Article | Year |
|---|---|
Antifibrotic effect of diethylcarbamazine combined with hesperidin against ethanol induced liver fibrosis in rats.
Topics: Animals; Antioxidants; Diethylcarbamazine; Ethanol; Hepatic Stellate Cells; Hesperidin; Hydroxyproli | 2017 |
Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
Topics: Actins; Animals; Biomarkers; Carbon Tetrachloride; Collagen Type I; Diethylcarbamazine; Down-Regulat | 2018 |
Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice.
Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Col | 2014 |